FDA Investigator LCDR Chad N Thompson

LCDR Chad N Thompson has inspections in 10 countries as of 01 Nov 2023. LCDR Chad N Thompson has collaborated with a combinined 5102 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
119
Last Inspection Date:
01 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100005808
Country:
United States of America, Spain, Italy, France, Germany, Netherlands, Denmark, Switzerland, Austria, Ireland
Co-Investigator(s):
Adam R Cooke, Aldo J Milone, Alice S Tsao, Allison A Aldridge, PhD, Amanda T Zick, Amy Kim, Amy W Yan Mai, Andrew F Cohen, Andrew J Barrowcliff, Andrew M Abramowitz, Ann B Okon, Anne Marie Dubrey, Armen H Youssoufian, Arthur F Walker, Arthur G Hurst, Ashley Polizzotto, Azza Talaat, Benton M Ketron, Bijoy Panicker, Bo Chi, PhD, Brian D Nicholson, Bruce G Cooper, Bruce H Mccullough, Candace Y Gomez Broughton, Carla A Norris, Carla J Lundi, Carley R Anderson, Carolyn J Cook, Caryn M Mcnab, Cassandra L Abellard, Catherine M Beer, Chad N Thomppson, Charisse K Green, Christina Capacci Daniel, PhD, Christopher Janik, Christopher T Middendorf, Christopher T Peters, Constance Y Fears, D Jennyxirakis Xiradakis, Dana A Razzano, Daniel L Aisen, Darren S Brown, David B Wieneke, David J Gomes, David M Mcnew, David R Delucia, Debra L Pagano, Demitria J Xiradakis, Denise L Terzian, Denise M Digiulio, Dennis Cantellops Paite, Diamond M Oden, Diane E Bruce, Diane M Fresch, Don H Bark, PhD, Donald G Gordon, Dr. Abhijit Raha, PhD, Dr. Carmelo Rosa, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Edmund F Mrak, Jr, Ellen M Landis, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Eric C Schmitt, Eric J Reisenauer, Erik W Koester, Erin C Hill, Felix Maldonado, Francis A Guidry, Frank Wackes, Gabriel Davila, Gam S Zamil, Gary T Greco, George C Amedro, Gerald B Seaborn, Jr, Gerard D Difiore, Gray, Guerlain Ulysse, Helen B Ricalde, Herbert M Corbello, Iram R Hassan, PhD, Isaac N Baah, J Paul Kirwan, PhD, Jacobson, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Jagon, James A Liubicich, James C Maclaughlin, James D Bridges, James I Giefer, James L Dunnie, Jr, Jason F Chancey, Jawaid Hamid, Jay T Wong, Jeffery A Hangartner, Jennifer Lalama, Jennifer M Gogley, Jens Fricke, Joan A Loreng, Joanne E King, Joanne M Schlossin, Jonathan G Matrisciano, Jose Acruz Gonzalez, Jose O Hernandez, Joseph Maselli, Joseph T Frost, Joshua D Lopez, Juan Rjimenez Garcia, Judy Keihl, Junho Pak, Kalavati Suvarna, PhD, Karen A Briggs, Karen L Kosar, Katherine E Jacobitz, Kathryn A Nagy, Katie L Penno, Kenneth G Klobus, Kerry D Noto, Kevin A Gonzalez, Kevin D Kallander, Kevin J Flessa, Kham Phommachanh, Kimberley A Ricketts, Kimberly M White, Kimberly Y Smithson, Kristy A Zielny, Kumar G Janoria, Kwong P Lee, Kyle J Spencer, Lakshmi Narasimhan, PhD, Lance M De Souza, MBA, Laura Fontan, MS, Lauren N Howard, Lauren N Smith, Laurie B Frazier, Lawrence H Patrick, Lawrence J Stringer, Linda Thai, Lisa B Orr, Lisa Hornback, Lisa M Romano, Lisa Mathew, Lori M Newman, Luis M Burgos, Luis M Burgos Medero, Lydia Irosas Marty, Marcia D Fields, Margaret E Sarles, Maria Joselopez Barragan, PhD, Marie Elena C Puleo, Marie F Morin, Mariza M Jafary, Mary F Finn, Mary M Finn, Massoud Motamed, Matthew B Casale, Maxwell Van Tassell, PhD, Meisha A Mandal, Melanie M Walker, Melissa A Henaghan, Meredith P Soehl, Investigator, Michael A Charles, Michael D Omeara, Michael F Skelly, PhD, Michael G Sinkevich, Michael J Verdi, Michael L Casner, Michael R Dominick, Michele L Obert, Michelle L Dragon Nagel, Michelle Y Clark Stuart, Milan S Mcgorty, Milos Dokmanovic, PhD, Mindy M Chou, Mohsen Rajabi Abhari, FDA, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Nancy A Saxenian, Nancy A Saxenian Emmons, Nicholas A Violand, Nicholas C Mendiola, Nicholas L Paulin, Niketa Patel, Omotunde O Osunsanmi, Parul M Patel, Patricia Fhughes Troost, Patrick C Klotzbuecher, Paul A Bonneau, Paul E Stein, Paul Mouris, Perez, Perry T Nichols, Peter M Trunk, Peter R Caparelli, Pratik S Upadhyay, DDC, Pushpa S Jayasekara, Rachael A Moliver, Rafael E Arroyo, Rajiv R Srivastava, Ramon E Martinez, Randi Lynn Bodoh, Randi Lynn Spencer, Raymond M Lam, Raymond T Oji, Rebecca E Dombrowski, Regina T Brown, Reyes Candau Chacon, PhD, Richard H Penta, Richard L Friedman, Richard Ledwidge (nmi), PhD, Rita F Monfort, Robert D Tollefsen, Robert J Maffei, Robert J Martin, Robert J Veitch, Roger F Zabinski, Roseline N Boateng, Roy R Rinc, Russ E Davis, Russell J Glapion, Saleem A Akhtar, Samantha J Bradley, Samina S Khan, Sandra A Hughes, Santiago Gallardo Johnson, Santos E Camara, Sarah Kennett, PhD, Sarah M Meng, Sateesh Kum Sathigari, Satheesh Thomas, Scott M Loughan, Scott R Izyk, Sean R Marcsisin, Simone E Pitts, Smith, Sneha S Patel, Sonia E Ortiz, Sony Mathews, Sripal R Mada, PhD, State Agency, Stephen D Brown, Steven C Madzo, Steven J Libal, Steven M Weinman, Sung K Kim, Susan M Jackson, Susant Hadman, Tammy Notto, Tammy S Notto, Tanya R Syffrard, Temar Q Williams, Terri L Dodds, Theresa Kirkham (NMI), Thomas J Arista, Thuy T Nguyen, LCDR, Tiffani D Wilson, Timothy T Kapsala, Tzanko Stantchev, Ucheabuchi C Chudi Nwankwor, Valerie A Potopsingh, Veronica Fuentes, MS, Virginia Carroll, PhD, Viviana R Ramirez, Wayne E Seifert, Wendy M Stone, William M Rennells, William P Chilton, Willie Wilson, Xiaohan Cai, PhD, Xiaohui Shen, Xiaokuang Lai, PhD, Yasamin Ameri, Yiyue Zhang (nmi), PhD, Yvette I Henry, Yvette I Johnson, Yvonne C Mcknight, Yvonne M Santiago, Zachary A Bogorad, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

LCDR Chad N Thompson's Documents

Publish Date Document Type Title
June, 2012 FDA 483 Asept Pak Inc. - Form 483, 2012-06-20
March, 2012 FDA 483 X-Gen Pharmaceuticals Inc. - Form 483, 2012-03-08
December, 2012 FDA 483 CENEXI - Form 483, 2012-12-11
June, 2010 FDA 483 Blenheim Pharmacal, Inc. - Form 483, 2010-06-01
May, 2015 EIR Curia New York, Inc. - EIR, 2015-05-22
April, 2015 FDA 483 Regeneron Pharmaceuticals, Inc. - Form 483, 2015-04-03
February, 2015 EIR N-Molecular, Inc. dba SOFIE - EIR, 2015-02-12
June, 2015 FDA 483 Haupt Pharma Wuelfing GmbH - Form 483, 2015-06-16
July, 2012 EIR Dipharma Francis S.r.l. - EIR, 2012-07-19
December, 2011 FDA 483 Asept Pak Inc. - Form 483, 2011-12-02
August, 2009 FDA 483 Ohm Laboratories, Inc. - Form 483, 2009-08-12
June, 2019 FDA 483 Infusion Options, Inc. - Form 483, 2019-07-08
January, 2014 FDA 483 Curia New York, Inc. - Form 483, 2014-01-15
March, 2015 FDA 483 Fallon Wellness Pharmacy, L.L.C. - Form 483, 2015-03-10
April, 2011 FDA 483 Ames Goldsmith Corp - Form 483, 2011-04-21
February, 2013 FDA 483 Delcath Systems Inc. - Form 483, 2013-02-15
June, 2018 EIR Haupt Pharma Latina S.r.l. - EIR, 2018-06-28
April, 2010 FDA 483 Ames Goldsmith Corp - Form 483, 2010-04-26
June, 2018 FDA 483 Haupt Pharma Latina S.r.l. - Form 483, 2018-06-28
December, 2016 FDA 483 Fallon Wellness Pharmacy, L.L.C. - Form 483, 2016-12-06
September, 2015 FDA 483 Pharmaceutic Labs, LLC - Form 483, 2015-09-23
January, 2018 EIR DSM Nutritional Products AG Zweigniederlassung Werk Sisseln - EIR, 2018-01-25
December, 2013 FDA 483 Response Curia Global, Inc. - Form 483R, 2014-01-29
March, 2010 FDA 483 Regeneron Pharmaceuticals, Inc. - Form 483, 2010-03-31
March, 2017 FDA 483 SterRx, LLC - Form 483, 2017-03-17
May, 2015 FDA 483 Curia New York, Inc. - Form 483, 2015-05-22
February, 2015 FDA 483 N-Molecular, Inc. dba SOFIE - Form 483, 2015-02-12
February, 2015 FDA 483 Response N-Molecular, Inc. dba SOFIE - Form 483R, 2015-03-04
October, 2012 FDA 483 MEDISCA Inc. - Form 483, 2012-10-24
December, 2013 EIR Curia Global, Inc. - EIR, 2013-12-12
August, 2015 FDA 483 N-Molecular, Inc. dba SOFIE - Form 483, 2015-08-07
January, 2012 FDA 483 Ames Goldsmith Corp - Form 483, 2012-01-26
July, 2010 FDA 483 Blenheim Pharmacal, Inc. - Form 483, 2010-07-28
February, 2014 FDA 483 MEDISCA Inc. - Form 483, 2014-02-27
May, 2012 FDA 483 MEDISCA Inc. - Form 483, 2012-05-30
December, 2013 FDA 483 Curia Global, Inc. - Form 483, 2013-12-12
January, 2010 FDA 483 SpecGx LLC - Form 483, 2010-01-27

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more